Fundamental components of healthcare in decline

Pfizer slashes R&D : Nature News

As reported in Nature News, and something that has been hotly debated in the general medical journals recently – industry-based drug discovery is in a severe decline. Perhaps the first tangible evidence that it has already started comes from declining budgets in discovery.

For many reasons, healthcare experts are seriously concerned about the future of medicine, with increasing expenditure, industry’s perverse incentives driving development, repeated failures in evidence-based medicine, the failed promise of ‘personal’ medicine, and no real solutions.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s